Biomerica Inc (BMRA) Gross Profit Margin starting from the fourth quarter 2026 to fourth quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Biomerica Inc   (NASDAQ: BMRA)


Biomerica Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMRA Gross Profit Margin (May 31 2026)
Q4 		(Feb 28 2026)
Q3 		(Nov 30 2025)
Q2 		(Aug 31 2025)
Q1 		(May 31 2025)
Q4
Y / Y Revenue Change 16.96 %
Seq. Revenue Change -11.25 %
Revenue In Millions $0.88
Gross Profit Margin -7.88 %
Gross Profit Margin Total Ranking #
Gross Profit In Millions $-0.07
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2026 Gross Profit Margin
Biomerica Inc achieved higher Gross Loss of 0 than a $-0.04 millions reported a quarter before.


Observing fourth quarter 2026 results within In Vitro & In Vivo Diagnostic Substances industry Biomerica Inc has achieved highest Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to , from total ranking in the previous quarter at 3648.
Learn about Gross Margin
BMRA's Gross Profit Margin fourth quarter 2026 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry #
Healthcare Sector #
Overall # 0

Gross Profit Margin Statistics
High Average Low
40.92 % 23.74 % 1.7 %
(Aug 31 2016)   (Feb 28 2025)


BMRA Gross Income Trends • More of BMRA's Profitabilty Ratios • BMRA Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
BMRA's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
BMRA's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for BMRA's Competitors
Gross Profit Margin Profit Margin for Biomerica Inc 's Suppliers
Gross Profit Margin Profit Margin for BMRA's Customers

You may also want to know
BMRA's Annual Growth Rates BMRA's Profitability Ratios BMRA's Asset Turnover Ratio BMRA's Dividend Growth
BMRA's Roe BMRA's Valuation Ratios BMRA's Financial Strength Ratios BMRA's Gross Profit Growth
BMRA's Roa BMRA's Inventory Turnover Ratio BMRA's Growth Rates BMRA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending May 31 2026, within In Vitro & In Vivo Diagnostic Substances Industry Gross Profit MarginMay 31 2026 MRQ Gross ProfitMay 31 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.